NICE recommends healthcare professionals ask people about gambling at health checks and GP appointments
NICE publishes final guidance on identifying, assessing, and managing gambling-related harms.
NICE publishes final guidance on identifying, assessing, and managing gambling-related harms.
We have also recommended osimertinib for routine use on the NHS today.
Recommendations will help organisations that evaluate new drugs establish whether their use will result in longer-term benefits for patients
For the first time, NICE has recommended an innovative new treatment to help stop babies, children and young people who are undergoing cancer treatment from losing their hearing.
An end of year summary from our chief executive, Dr Sam Roberts.
A guide to the severity modifier and how it is leading to more positive recommendations overall from NICE.
Introducing the Medicines and Medical Devices Access Initiative (MMD): a new collaboration that aims to improve patient access to safe, clinically and cost-effective healthcare products.
We explore the ongoing debate around NICE’s cost-effectiveness thresholds and what the future holds.